What is the projected market valuation of the Plant Genotyping Equipment Market by 2035?

The projected market valuation for the Plant Genotyping Equipment Market is 4.597 USD Billion by 2035. Read More

What was the market valuation of the Plant Genotyping Equipment Market in 2024?

The overall market valuation was 2.181 USD Billion in 2024. Read More

What is the expected CAGR for the Plant Genotyping Equipment Market during the forecast period 2025 - 2035?

The expected CAGR for the Plant Genotyping Equipment Market during the forecast period 2025 - 2035 is 7.01%. Read More

What are the main segments of the Plant Genotyping Equipment Market?

The main segments include Genotyping Technology, Testing Method, End User, Application Area, and Equipment Type. Read More

What was the valuation of SNP Genotyping in 2024?

The valuation of SNP Genotyping was 0.654 USD Billion in 2024. Read More

What is the projected valuation for Non-Destructive Testing by 2035?

The projected valuation for Non-Destructive Testing is 3.205 USD Billion by 2035. Read More

How much is the market for Agricultural Biotechnology Companies expected to grow by 2035?

The market for Agricultural Biotechnology Companies is expected to grow to 1.845 USD Billion by 2035. Read More

What is the valuation of PCR Machines in 2024?

The valuation of PCR Machines was 0.654 USD Billion in 2024. Read More

Plant Genotyping Equipment Market

Q: Which companies are considered key players in the Plant Genotyping Equipment Market?

Key players in the market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Qiagen, LGC Limited, Eurofins Scientific, Genomatix Software, and PerkinElmer. Read More

Q: What applications are driving growth in the Plant Genotyping Equipment Market?

Applications driving growth include Plant Breeding, Disease Resistance, Genetic Diversity Analysis, and Crop Improvement. Read More

ID: MRFR/HC/39474-HCR

111 Pages

Satyendra Maurya

Last Updated: April 06, 2026

Plant Genotyping Equipment Market Research Report: By Genotyping Technology (SNP Genotyping, SSR Genotyping, Next-Generation Sequencing, DNA Microarrays), By Destructive vs. Non-Destructive Testing (Destructive Testing, Non-Destructive Testing), By End User (Research Institutions, Agricultural Biotechnology Companies, Government Agencies), By Application Area (Plant Breeding, Disease Resistance, Genetic Diversity Analysis, Crop Improvement), By Equipment Type (PCR Machines, Electrophoresis Equipment, Sequencing Systems, Sample Preparation Equipment) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Plant Genotyping Equipment Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)7.01%

2024 Market Size$ 2.18 Billion

2025 Market Size$ 2.33 Billion

2035 Market Size$ 4.6 Billion

Key Players

Illumina

Thermo Fisher Scientific

Agilent Technologies

Bio-Rad Laboratories

Qiagen

LGC Limited

Trends

Technological Advancements
Sustainability Focus
Increased Research Investment

Opportunities

Growing Focus on Crop Resilience
Government Initiatives and Funding
Integration of Genomics in Agriculture

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Genotyping Technology (USD Billion)
  1. 4.1.1 SNP Genotyping
  2. 4.1.2 SSR Genotyping
  3. 4.1.3 Next-Generation Sequencing
  4. 4.1.4 DNA Microarrays
2. 4.2 Chemicals and Materials, BY Testing Method (USD Billion)
  1. 4.2.1 Destructive Testing
  2. 4.2.2 Non-Destructive Testing
3. 4.3 Chemicals and Materials, BY End User (USD Billion)
  1. 4.3.1 Research Institutions
  2. 4.3.2 Agricultural Biotechnology Companies
  3. 4.3.3 Government Agencies
4. 4.4 Chemicals and Materials, BY Application Area (USD Billion)
  1. 4.4.1 Plant Breeding
  2. 4.4.2 Disease Resistance
  3. 4.4.3 Genetic Diversity Analysis
  4. 4.4.4 Crop Improvement
5. 4.5 Chemicals and Materials, BY Equipment Type (USD Billion)
  1. 4.5.1 PCR Machines
  2. 4.5.2 Electrophoresis Equipment
  3. 4.5.3 Sequencing Systems
  4. 4.5.4 Sample Preparation Equipment
6. 4.6 Chemicals and Materials, BY Region (USD Billion)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Illumina (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Thermo Fisher Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Agilent Technologies (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Bio-Rad Laboratories (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Qiagen (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 LGC Limited (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Eurofins Scientific (LU)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Genomatix Software (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 PerkinElmer (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
4. 6.4 US MARKET ANALYSIS BY TESTING METHOD
5. 6.5 US MARKET ANALYSIS BY END USER
6. 6.6 US MARKET ANALYSIS BY APPLICATION AREA
7. 6.7 US MARKET ANALYSIS BY EQUIPMENT TYPE
8. 6.8 CANADA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
9. 6.9 CANADA MARKET ANALYSIS BY TESTING METHOD
10. 6.10 CANADA MARKET ANALYSIS BY END USER
11. 6.11 CANADA MARKET ANALYSIS BY APPLICATION AREA
12. 6.12 CANADA MARKET ANALYSIS BY EQUIPMENT TYPE
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
15. 6.15 GERMANY MARKET ANALYSIS BY TESTING METHOD
16. 6.16 GERMANY MARKET ANALYSIS BY END USER
17. 6.17 GERMANY MARKET ANALYSIS BY APPLICATION AREA
18. 6.18 GERMANY MARKET ANALYSIS BY EQUIPMENT TYPE
19. 6.19 UK MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
20. 6.20 UK MARKET ANALYSIS BY TESTING METHOD
21. 6.21 UK MARKET ANALYSIS BY END USER
22. 6.22 UK MARKET ANALYSIS BY APPLICATION AREA
23. 6.23 UK MARKET ANALYSIS BY EQUIPMENT TYPE
24. 6.24 FRANCE MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
25. 6.25 FRANCE MARKET ANALYSIS BY TESTING METHOD
26. 6.26 FRANCE MARKET ANALYSIS BY END USER
27. 6.27 FRANCE MARKET ANALYSIS BY APPLICATION AREA
28. 6.28 FRANCE MARKET ANALYSIS BY EQUIPMENT TYPE
29. 6.29 RUSSIA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
30. 6.30 RUSSIA MARKET ANALYSIS BY TESTING METHOD
31. 6.31 RUSSIA MARKET ANALYSIS BY END USER
32. 6.32 RUSSIA MARKET ANALYSIS BY APPLICATION AREA
33. 6.33 RUSSIA MARKET ANALYSIS BY EQUIPMENT TYPE
34. 6.34 ITALY MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
35. 6.35 ITALY MARKET ANALYSIS BY TESTING METHOD
36. 6.36 ITALY MARKET ANALYSIS BY END USER
37. 6.37 ITALY MARKET ANALYSIS BY APPLICATION AREA
38. 6.38 ITALY MARKET ANALYSIS BY EQUIPMENT TYPE
39. 6.39 SPAIN MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
40. 6.40 SPAIN MARKET ANALYSIS BY TESTING METHOD
41. 6.41 SPAIN MARKET ANALYSIS BY END USER
42. 6.42 SPAIN MARKET ANALYSIS BY APPLICATION AREA
43. 6.43 SPAIN MARKET ANALYSIS BY EQUIPMENT TYPE
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY TESTING METHOD
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY END USER
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY APPLICATION AREA
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY EQUIPMENT TYPE
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
51. 6.51 CHINA MARKET ANALYSIS BY TESTING METHOD
52. 6.52 CHINA MARKET ANALYSIS BY END USER
53. 6.53 CHINA MARKET ANALYSIS BY APPLICATION AREA
54. 6.54 CHINA MARKET ANALYSIS BY EQUIPMENT TYPE
55. 6.55 INDIA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
56. 6.56 INDIA MARKET ANALYSIS BY TESTING METHOD
57. 6.57 INDIA MARKET ANALYSIS BY END USER
58. 6.58 INDIA MARKET ANALYSIS BY APPLICATION AREA
59. 6.59 INDIA MARKET ANALYSIS BY EQUIPMENT TYPE
60. 6.60 JAPAN MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
61. 6.61 JAPAN MARKET ANALYSIS BY TESTING METHOD
62. 6.62 JAPAN MARKET ANALYSIS BY END USER
63. 6.63 JAPAN MARKET ANALYSIS BY APPLICATION AREA
64. 6.64 JAPAN MARKET ANALYSIS BY EQUIPMENT TYPE
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY TESTING METHOD
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY END USER
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY APPLICATION AREA
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY EQUIPMENT TYPE
70. 6.70 MALAYSIA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
71. 6.71 MALAYSIA MARKET ANALYSIS BY TESTING METHOD
72. 6.72 MALAYSIA MARKET ANALYSIS BY END USER
73. 6.73 MALAYSIA MARKET ANALYSIS BY APPLICATION AREA
74. 6.74 MALAYSIA MARKET ANALYSIS BY EQUIPMENT TYPE
75. 6.75 THAILAND MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
76. 6.76 THAILAND MARKET ANALYSIS BY TESTING METHOD
77. 6.77 THAILAND MARKET ANALYSIS BY END USER
78. 6.78 THAILAND MARKET ANALYSIS BY APPLICATION AREA
79. 6.79 THAILAND MARKET ANALYSIS BY EQUIPMENT TYPE
80. 6.80 INDONESIA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
81. 6.81 INDONESIA MARKET ANALYSIS BY TESTING METHOD
82. 6.82 INDONESIA MARKET ANALYSIS BY END USER
83. 6.83 INDONESIA MARKET ANALYSIS BY APPLICATION AREA
84. 6.84 INDONESIA MARKET ANALYSIS BY EQUIPMENT TYPE
85. 6.85 REST OF APAC MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
86. 6.86 REST OF APAC MARKET ANALYSIS BY TESTING METHOD
87. 6.87 REST OF APAC MARKET ANALYSIS BY END USER
88. 6.88 REST OF APAC MARKET ANALYSIS BY APPLICATION AREA
89. 6.89 REST OF APAC MARKET ANALYSIS BY EQUIPMENT TYPE
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
92. 6.92 BRAZIL MARKET ANALYSIS BY TESTING METHOD
93. 6.93 BRAZIL MARKET ANALYSIS BY END USER
94. 6.94 BRAZIL MARKET ANALYSIS BY APPLICATION AREA
95. 6.95 BRAZIL MARKET ANALYSIS BY EQUIPMENT TYPE
96. 6.96 MEXICO MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
97. 6.97 MEXICO MARKET ANALYSIS BY TESTING METHOD
98. 6.98 MEXICO MARKET ANALYSIS BY END USER
99. 6.99 MEXICO MARKET ANALYSIS BY APPLICATION AREA
100. 6.100 MEXICO MARKET ANALYSIS BY EQUIPMENT TYPE
101. 6.101 ARGENTINA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
102. 6.102 ARGENTINA MARKET ANALYSIS BY TESTING METHOD
103. 6.103 ARGENTINA MARKET ANALYSIS BY END USER
104. 6.104 ARGENTINA MARKET ANALYSIS BY APPLICATION AREA
105. 6.105 ARGENTINA MARKET ANALYSIS BY EQUIPMENT TYPE
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY TESTING METHOD
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION AREA
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY EQUIPMENT TYPE
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY TESTING METHOD
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY END USER
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION AREA
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY EQUIPMENT TYPE
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY TESTING METHOD
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY END USER
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION AREA
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY EQUIPMENT TYPE
122. 6.122 REST OF MEA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
123. 6.123 REST OF MEA MARKET ANALYSIS BY TESTING METHOD
124. 6.124 REST OF MEA MARKET ANALYSIS BY END USER
125. 6.125 REST OF MEA MARKET ANALYSIS BY APPLICATION AREA
126. 6.126 REST OF MEA MARKET ANALYSIS BY EQUIPMENT TYPE
127. 6.127 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF CHEMICALS AND MATERIALS
130. 6.130 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
131. 6.131 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
132. 6.132 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
133. 6.133 CHEMICALS AND MATERIALS, BY GENOTYPING TECHNOLOGY, 2024 (% SHARE)
134. 6.134 CHEMICALS AND MATERIALS, BY GENOTYPING TECHNOLOGY, 2024 TO 2035 (USD Billion)
135. 6.135 CHEMICALS AND MATERIALS, BY TESTING METHOD, 2024 (% SHARE)
136. 6.136 CHEMICALS AND MATERIALS, BY TESTING METHOD, 2024 TO 2035 (USD Billion)
137. 6.137 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
138. 6.138 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Billion)
139. 6.139 CHEMICALS AND MATERIALS, BY APPLICATION AREA, 2024 (% SHARE)
140. 6.140 CHEMICALS AND MATERIALS, BY APPLICATION AREA, 2024 TO 2035 (USD Billion)
141. 6.141 CHEMICALS AND MATERIALS, BY EQUIPMENT TYPE, 2024 (% SHARE)
142. 6.142 CHEMICALS AND MATERIALS, BY EQUIPMENT TYPE, 2024 TO 2035 (USD Billion)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.2.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.2.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.2.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.2.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.3.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.3.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.3.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.3.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.4.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.4.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.4.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.4.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.5.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.5.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.5.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.5.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.6.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.6.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.6.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.6.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.7.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.7.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.7.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.7.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.8.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.8.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.8.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.8.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.9.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.9.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.9.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.9.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.10.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.10.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.10.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.10.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.11.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.11.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.11.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.11.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.12.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.12.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.12.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.12.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.13.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.13.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.13.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.13.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.14.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.14.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.14.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.14.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.15.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.15.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.15.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.15.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.16.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.16.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.16.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.16.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.17.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.17.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.17.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.17.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.18.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.18.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.18.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.18.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.19.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.19.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.19.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.19.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.20.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.20.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.20.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.20.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.21.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.21.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.21.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.21.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.22.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.22.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.22.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.22.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.23.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.23.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.23.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.23.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.24.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.24.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.24.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.24.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.25.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.25.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.25.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.25.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.26.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.26.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.26.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.26.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.27.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.27.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.27.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.27.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.28.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.28.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.28.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.28.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.29.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.29.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.29.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.29.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.30.2 BY TESTING METHOD, 2025-2035 (USD Billion)
  3. 7.30.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.30.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
  5. 7.30.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Chemicals and Materials Market Segmentation

Chemicals and Materials By Genotyping Technology (USD Billion, 2025-2035)

SNP Genotyping
SSR Genotyping
Next-Generation Sequencing
DNA Microarrays

Chemicals and Materials By Testing Method (USD Billion, 2025-2035)

Destructive Testing
Non-Destructive Testing

Chemicals and Materials By End User (USD Billion, 2025-2035)

Research Institutions
Agricultural Biotechnology Companies
Government Agencies

Chemicals and Materials By Application Area (USD Billion, 2025-2035)

Plant Breeding
Disease Resistance
Genetic Diversity Analysis
Crop Improvement

Chemicals and Materials By Equipment Type (USD Billion, 2025-2035)

PCR Machines
Electrophoresis Equipment
Sequencing Systems
Sample Preparation Equipment

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”